• Work with us
  • External Contractors
Fondazione Toscana Life Sciences
  • IT
  • EN
Toscana Life Sciences
  • THE FOUNDATION
    • Organization
    • History
    • Membership
    • The Legislative Decree No. 231/2001
  • Activity
  • Cluster
  • ITS VITA
  • BIOINCUBATOR
    • Join the Bioincubator
    • Incubated companies
    • Research groups
    • Affiliated companies
  • Services
    • Business development services
    • Research services
    • Incubation services
    • Protection of intellectual property
  • Projects
    • Monoclonal Antibody Discovery (MAD) LAB
    • ERC Advanced Grant VACCIBIOME
    • TUMOUR IMMUNOLOGY UNIT
    • BOTANICALS LAB
    • Data Science for Health (DaScH) Lab
    • Regions4PerMed
    • IDF SHARID
    • BORNTOGEtTHERe
    • SINO-EU‐PERMED
    • Orphan diseases
  • Disseminating
    • TLS Open Doors
    • Scientists for a day
    • Science + Economy = Business
    • Researcher’s Night
    • European Biotech Week
  • TLS4Covid19
  • Stories
Enter any keyword and press enter


Anna Laura Brai

Pharmaceutical Chemist Lead Discovery Siena



Download Watch video


Looking to gain time


LEAD DISCOVERY SIENA

From research to drug: it’s a matter of chemistry


The idea of Lead Discovery Siena (LDS) was born in 2000 from a group of researchers and teachers of the Siena University Pharmaceutical, Chemistry and Technology Department. The Company was founded in 2012 as a small University spin off and represents nowadays a successful institution involved in the rational organization of new molecules of pharmaceutical interest through modeling techniques, library synthesis and pharmacological evaluation.
The Company, managed by one of the founders, Maurizio Botta, teacher at Siena University, is especially involved in projects concerning the oncological and anti-infective field. LDS research is focused on cancer and, in particular, on neuroblastoma, a specific kind of brain tumor which afflicts children, and glioblastoma, both without efficient therapies. The President, Maurizio Botta, explains in his interview the targets reached thanks to a molecules drawing and synthesis project, able to determine an important disease regression.
Anna Laura Brai, Chemist at LDS, explains then the researcher’s job in the company, from the first phase of identification of the target protein most indicated for the development of drugs, until drug synthesis and bio-distribution tests.
LDS also established many cooperations with academic institutions, hospitals and national and international research centres for the development of projects and know how exchange in the field of oncology and anti-infectives.
LDS is incubated in TLS since 2016.

For more information: leaddiscoverysiena.it/

Read more

Exosomics Siena SpA

Cancer screening and diagnosis with exosomes
read more


Fondazione Umberto Di Mario

Diabetes is not invincible
read more


ISTITUTO TOSCANO TUMORI

Cancer can be defeated through the cooperation
read more


SIENA IMAGING

The human brain as you have never seen it
read more


T4ALL

Technology at the service of everyone
read more


Fondazione Toscana Life Sciences
Via Fiorentina, 1
53100 Siena – ITALIA

  • tel +39 0577 231211
  • fax +39 0577 43444
  • info@toscanalifesciences.org; info@pec.fondazionetls.org

Twitter Feeds

🗣Torna la nuova edizione di “Meet in Italy for Life Sciences StartUp Breeding 2022 – MIT4LS SUB2022” 🚀 ⏰La call è a…

@FondazioneTLS 2 Days Ago

🗣Tornano le edizioni 2022 di MedFIT, NutrEvent e BioFit: tre dei principali appuntamenti internazionali dedicati al…

@FondazioneTLS 5 Days Ago

🗣Tappa senese oggi per Smart Future Academy Italia, progetto che ha lo scopo di facilitare le attività di orientame…

@FondazioneTLS About a Week Ago

Contatti

    Concedo il consenso al trattamento dei dati personali secondo la nostra Privacy Policy per poter essere contattato da Fondazione Toscana Life Sciences.

©2015-2021 - Fondazione Toscana Life Sciences - P.I. 01194710529 - Codice SDI: SUBM70N - Privacy - Cookie Policy